EQUITY PHARMACEUTICALS — South Africa · eTender award records · Supplier record: 1 award notices, all years (January 2025); 1 since January 2024 (1 buyer); 3rd rank in the line (of 15 suppliers · 8.3%); 4 buyers never served (9 notices in the line from them).
Assay record ASY-ZA-1LQSYVT04I · Cite as: Assay Systems, “EQUITY PHARMACEUTICALS in the eTender register for South Africa”, https://assay-systems.com/register/za/equity-pharmaceuticals/
1
award notices, all years
January 2025
1
since January 2024
1 buyer
3rd
rank in the line
of 15 suppliers · 8.3%
4
buyers never served
9 notices in the line from them
Own record by year
award notices, 2016 onward
1
20162017201820192020202120222023202420252026
Who buys from EQUITY PHARMACEUTICALS
since January 2024
1buyers
1notices
100%top buyer
Health100.0%
1 notice
The line
since January 2024
12award notices
5buyers
15suppliers
70.6%held by top ten
Miscellaneous drug categories (UNSPSC 51210000)
5
6
1
202420252026Jan–Sep
3rdof 15 suppliers
1notices name EQUITY PHARMACEUTICALS
8.3%share of the line
33.3%of 3 notices from Health
14new suppliers since 2024
Buyers that buy the line and never named EQUITY PHARMACEUTICALS
Source: contract awards published by the National Treasury of South Africa (eTender) in the Open Contracting Data Standard (data.open-contracting.org), licensed under ODC PDDL 1.0; awards from January 2016 to 30 September 2026, accessed 15 October 2026.Assay Systems has changed the data.